| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459395 | Radiotherapy and Oncology | 2017 | 9 Pages |
Abstract
Patients with CVD may be at higher risk of RP. However, CVD patients may be offered curative thoracic RT with particular attention to risk-reduction strategies and maintaining recommended dose constraints as described in this study.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kevin Diao, Yu-Hui Chen, Paul J. Catalano, Stephanie Lee, Nastaran Milani, Joseph H. Killoran, Elizabeth H. Baldini, Aileen B. Chen, David E. Kozono, Raymond H. Mak,